Skip to main content

Dietary Omega Polyunsaturated Fatty Acid Intake and Patient-Reported Outcomes in Systemic Lupus Erythematosus: The Michigan Lupus Epidemiology and Surveillance Program.

Citation
Charoenwoodhipong, P., et al. “Dietary Omega Polyunsaturated Fatty Acid Intake And Patient-Reported Outcomes In Systemic Lupus Erythematosus: The Michigan Lupus Epidemiology And Surveillance Program.”. Arthritis Care & Research, pp. 874-881.
Center University of Michigan
Author Prae Charoenwoodhipong, Sioban D Harlow, Wendy Marder, Afton L Hassett, Joseph McCune, Caroline Gordon, Charles G Helmick, Kamil E Barbour, Lu Wang, Peter Mancuso, Emily C Somers, Suzanna M Zick
Abstract

OBJECTIVE: To examine associations between dietary intake of omega-3 (n-3; generally antiinflammatory) and omega-6 (n-6; generally proinflammatory) fatty acids and patient-reported outcomes in systemic lupus erythematosus (SLE).

METHODS: This study was based on the population-based Michigan Lupus Epidemiology and Surveillance cohort. Estimates of n-3 and n-6 intake were derived from Diet History Questionnaire II items (past year with portion size version). Patient-reported outcomes included self-reported lupus activity (Systemic Lupus Activity Questionnaire [SLAQ]). Multivariable regression, adjusted for age, sex, race, and body mass index, was used to assess associations between absolute intake of n-3 and n-6, as well as the n-6:n-3 ratio, and patient-reported outcomes.

RESULTS: Among 456 SLE cases, 425 (93.2%) were female, 207 (45.4%) were African American, and the mean ± SD age was 52.9 ± 12.3 years. Controlling for potential confounders, the average SLAQ score was significantly higher by 0.3 points (95% confidence interval [95% CI] 0.1, 0.6; P = 0.013) with each unit increase of the n-6:n-3 ratio. Both lupus activity and Patient-Reported Outcomes Measurement Information System (PROMIS) sleep disturbance scores were lower with each 1-gram/1,000 kcal increase of n-3 fatty acids (SLAQ regression coefficient β = -0.8 [95% CI -1.6, 0.0]; P = 0.055; PROMIS sleep β = -1.1 [95% CI -2.0, -0.2]; P = 0.017). Higher n-3 intakes were nonsignificantly associated with lower levels of depressive symptoms and comorbid fibromyalgia, and with higher quality of life, whereas results for the n6:n3 ratio trended in the opposite direction.

CONCLUSION: This population-based study suggests that higher dietary intake of n-3 fatty acids and lower n-6:n-3 ratios are favorably associated with patient-reported outcomes in SLE, particularly self-reported lupus activity and sleep quality.

Year of Publication
2020
Journal
Arthritis care & research
Volume
72
Issue
7
Number of Pages
874-881
Date Published
07/2020
ISSN Number
2151-4658
DOI
10.1002/acr.23925
Alternate Journal
Arthritis Care Res (Hoboken)
PMID
31074595
PMCID
PMC6842394
Download citation